| Revolution Medicines Announces Planned Leadership Transition for Steve Kelsey, M.D. |
Globe Newswire |
06/22 |
08:00 |
| BitFuFu Announces US$5 Million Share Repurchase Program |
Globe Newswire |
06/22 |
08:00 |
| Lifetime Brands, Inc. Announces Results of 2026 Annual Meeting |
Globe Newswire |
06/22 |
08:00 |
| Hyperion DeFi and Blockdaemon Partner to Expand Institutional Hyperliquid Staking Infrastructure |
Globe Newswire |
06/22 |
08:00 |
| BiggerPockets Appoints Active Real Estate Investor Eric Augustyn as CEO, Ushering in a New Era of Platform Innovation |
Globe Newswire |
06/22 |
08:00 |
| Banks Deny. We Defy.™ New Federal Reserve Data Confirms the Funding Gap Crushing Small Businesses, and CredFin Is Helping Thousands Fight Back |
Globe Newswire |
06/22 |
08:00 |
| NorthStar Secures Over CAD$40M with 3 Canadian Space Division to Advance Sovereign Space Domain Awareness |
Globe Newswire |
06/22 |
08:00 |
| GrowGeneration to Present at the iAccess Alpha Virtual Best Ideas Summer Investment Conference 2026 on June 23, 2026 |
Globe Newswire |
06/22 |
08:00 |
| Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD) |
Globe Newswire |
06/22 |
08:00 |
| EagleNXT Secures Order of eBee VISION ISR and eBee TAC Systems from Asia Pacific Customer |
Globe Newswire |
06/22 |
08:00 |
| Westport Announces US$10 Million Registered Direct Offering and Concurrent Private Placement Priced At-The-Market Under Nasdaq Rules |
Globe Newswire |
06/22 |
08:00 |
| Rezolve Ai Powers New Mashreq and Visa Everyday Cashback Program, Bringing AI-Enabled Card Linked Offers to UAE Cardholders |
Globe Newswire |
06/22 |
08:00 |
| NordLayer Named a Winner in the Expert Insights Cybersecurity Awards Summer 2026 for Network Security |
Globe Newswire |
06/22 |
08:00 |
| Veea Strengthens Executive Leadership Team to Accelerate its Commercial Growth and Market Expansion |
Globe Newswire |
06/22 |
08:00 |
| Taysha Gene Therapies Announces Completion of Dosing in REVEAL Pivotal Trial and Reports Longer-Term Clinical Data from Part A of REVEAL Phase 1/2 Trials Evaluating TSHA-102 for Rett Syndrome |
Globe Newswire |
06/22 |
08:00 |
| Amaero Expands Powder Capacity Ahead of Schedule |
Globe Newswire |
06/22 |
08:00 |
| Castor Maritime Inc. Announces Vessel Acquisition |
Globe Newswire |
06/22 |
07:45 |
| Irby Celebrates 100 Years of Growth, Partnership and Industry Leadership |
Globe Newswire |
06/22 |
07:41 |
| Nuvectis Announces Strategic Portfolio Expansion via License Agreement for Ex-China Rights with Haisco Pharmaceutical Group for Two Potentially Best-In Class Clinical-Stage Compounds |
Globe Newswire |
06/22 |
07:30 |
| Quantum Cyber Issues Letter to Shareholders |
Globe Newswire |
06/22 |
07:30 |
| BrainsWay Reports Favorable Coverage for Accelerated Deep TMS™ Rises to Over 57 Million Covered Lives |
Globe Newswire |
06/22 |
07:30 |
| FDA Grants Rolling Review of Palvella’s QTORIN™ Rapamycin NDA for Microcystic Lymphatic Malformations |
Globe Newswire |
06/22 |
07:30 |
| SL Green Realty Corp. to Release Second Quarter 2026 Financial Results After Market Close on July 22, 2026 |
Globe Newswire |
06/22 |
07:30 |
| Medicus Pharma to Showcase SkinJect® Registrational Strategy and Teverelix® Precision Medicine Program at Bio International 2026 |
Globe Newswire |
06/22 |
07:30 |
| Streamex Corp. Announces May 2026 Yield Dividend Distribution for GLDY |
Globe Newswire |
06/22 |
07:30 |
